African Journal of Infectious Diseases Research

ISSN 2756-3340

Table of Contents 2025

African Journal of Infectious Diseases Research | Vol. 12, No. 4, April 2025 | pp. 193-204

DOI: 10.46882/AJIDR/148717

Article Type: Research Article

Title: Neonatal sepsis etiology and antimicrobial resistance trends in level-three neonatal intensive care units

Names of Authors: Nadia Al-Kuwari¹, Benjamin Osei², Sophie Laurent³*

Authors’ Affiliations: ¹Department of Neonatology, Qatar University, Doha, Qatar. ²Department of Child Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. ³Department of Pediatrics, University of Geneva, Geneva, Switzerland.

Abstract: Neonatal sepsis remains a leading cause of newborn mortality globally, complicated by the rapid emergence of multidrug-resistant Gram-negative pathogens. This study investigated the bacterial etiology and antimicrobial resistance profiles of early-onset and late-onset neonatal sepsis. Blood cultures were obtained from 550 neonates with clinical signs of sepsis across three tertiary neonatal intensive care units. Culture-proven sepsis was confirmed in 26.2 percent of neonates, with Klebsiella pneumoniae (31.9 percent), Acinetobacter baumannii (22.2 percent), and Staphylococcus aureus (18.8 percent) predominating. Resistance to first-line ampicillin and gentamicin exceeded 72.0 percent among Gram-negative isolates, while overall sepsis-related mortality reached 21.5 percent. Updating empirical neonatal antibiotic guidelines and enforcing strict hand hygiene protocols are urgently required to improve newborn survival.

Keywords: Neonatal sepsis, Antimicrobial resistance, Klebsiella pneumoniae, Neonatal intensive care, Blood culture

Citation: Al-Kuwari N, Osei B, Laurent S (2026). Neonatal sepsis etiology and antimicrobial resistance trends in level-three neonatal intensive care units. African Journal of Infectious Diseases Research, 12(4): 193–204. DOI: 10.46882/AJIDR/148717

Manuscript Timeline: Received: February 22, 2026; Revised: March 25, 2026; Accepted: April 10, 2026; Published: April 30, 2026

African Journal of Infectious Diseases Research | Vol. 12, No. 4, April 2025 | pp. 181-192

DOI: 10.46882/AJIDR/148716

Article Type: Research Article

Title: Clinical presentation and molecular epidemiology of Chikungunya virus outbreaks in coastal urban centers

Names of Authors: Halima Suleiman¹, Alejandro Gomez², Katarzyna Nowak³*

Authors’ Affiliations: ¹Department of Epidemiology and Biostatistics, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania. ²Department of Virology, National University of Colombia, Bogotá, Colombia. ³Institute of Maritime and Tropical Medicine, Medical University of Gdańsk, Gdańsk, Poland.

Abstract: Chikungunya virus causes acute febrile illness accompanied by severe, debilitating polyarthralgia that can persist for months after initial infection. We sought to characterize the clinical spectrum and circulating viral lineages during a recent coastal outbreak. Acute-phase serum samples from 390 patients presenting with fever and joint pain were analyzed using multiplex RT-PCR and phylogenetic sequencing. Chikungunya virus RNA was detected in 41.3 percent of patients, with all sequenced isolates clustering within the East/Central/South African genotype. Persistent arthralgia lasting beyond ninety days was reported by 38.5 percent of confirmed cases, particularly among female patients over forty-five years old. Integrated Aedes mosquito control and long-term rheumatologic follow-up care are critical to mitigating outbreak morbidity.

Keywords: Chikungunya virus, Polyarthralgia, Molecular epidemiology, Aedes mosquitoes, Outbreak surveillance

Citation: Suleiman H, Gomez A, Nowak K (2026). Clinical presentation and molecular epidemiology of Chikungunya virus outbreaks in coastal urban centers. African Journal of Infectious Diseases Research, 12(4): 181–192. DOI: 10.46882/AJIDR/148716

Manuscript Timeline: Received: February 21, 2026; Revised: March 24, 2026; Accepted: April 09, 2026; Published: April 30, 2026

African Journal of Infectious Diseases Research | Vol. 12, No. 4, April 2025 | pp. 169-180

DOI: 10.46882/AJIDR/148715

Article Type: Research Article

Title: Epidemiology and azole resistance profiles of Aspergillus fumigatus in patients with chronic pulmonary aspergillosis

Names of Authors: Youssef Benali¹, Marit Van Dijk², Wei-Lin Chang³*

Authors’ Affiliations: ¹Department of Pneumology, Hassan II University of Casablanca, Casablanca, Morocco. ²Center of Expertise in Mycology, Radboud University Medical Center, Nijmegen, Netherlands. ³Department of Internal Medicine, Taipei Medical University, Taipei, Taiwan.

Abstract: Chronic pulmonary aspergillosis is a progressive fungal lung disease that frequently complicates healed tuberculosis cavities and chronic obstructive pulmonary disease. In this study, we assessed the prevalence of Aspergillus fumigatus and triazole resistance mutations among patients with chronic cavitary lung lesions. Sputum and bronchoalveolar lavage samples from 265 patients were cultured on Sabouraud dextrose agar, followed by antifungal susceptibility testing and cyp51A gene sequencing. Aspergillus fumigatus was isolated in 35.8 percent of patients, with itraconazole and voriconazole resistance detected in 12.6 percent of isolates. The TR34/L98H environmental resistance mutation accounted for 75.0 percent of triazole-resistant strains. Routine antifungal susceptibility testing is essential before initiating long-term oral triazole therapy in endemic post-tuberculosis cohorts.

Keywords: Chronic pulmonary aspergillosis, Aspergillus fumigatus, Triazole resistance, Post-tuberculosis lung disease, cyp51A mutation

Citation: Benali Y, Van Dijk M, Chang WL (2026). Epidemiology and azole resistance profiles of Aspergillus fumigatus in patients with chronic pulmonary aspergillosis. African Journal of Infectious Diseases Research, 12(4): 169–180. DOI: 10.46882/AJIDR/148715

Manuscript Timeline: Received: February 20, 2026; Revised: March 23, 2026; Accepted: April 08, 2026; Published: April 30, 2026

African Journal of Infectious Diseases Research | Vol. 12, No. 4, April 2026 | pp. 157-168

DOI: 10.46882/AJIDR/148714

Article Type: Research Article

Title: Methicillin-resistant Staphylococcus aureus nasal carriage and surgical site infection rates following orthopedic implant procedures

Names of Authors: Connor MacLeod¹, Ananya Rao², Lucas Oliveira³*

Authors’ Affiliations: ¹Department of Orthopedic Surgery, University of Edinburgh, Edinburgh, United Kingdom. ²Department of Clinical Microbiology, Manipal Academy of Higher Education, Manipal, India. ³Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

Abstract: Nasal colonization with methicillin-resistant Staphylococcus aureus is a recognized endogenous reservoir for postoperative surgical site infections in orthopedic surgery. This study evaluated preoperative nasal carriage rates and their association with deep implant-related infections. Nasal swabs were collected from 480 patients prior to elective arthroplasty and screened via chromogenic agar and mecA gene PCR. Preoperative MRSA colonization was detected in 11.5 percent of patients, and postoperative surgical site infections developed in 14.5 percent of carriers compared to 2.1 percent of non-carriers. Molecular typing confirmed genetic concordance between preoperative nasal isolates and subsequent wound pathogens in 87.5 percent of infected carriers. Preoperative screening combined with targeted mupirocin decolonization and vancomycin prophylaxis significantly reduces prosthetic joint infection risks.

Keywords: Methicillin-resistant Staphylococcus aureus, Nasal carriage, Surgical site infection, Orthopedic implants, Decolonization

Citation: MacLeod C, Rao A, Oliveira L (2026). Methicillin-resistant Staphylococcus aureus nasal carriage and surgical site infection rates following orthopedic implant procedures. African Journal of Infectious Diseases Research, 12(4): 157–168. DOI: 10.46882/AJIDR/148714

Manuscript Timeline: Received: February 19, 2026; Revised: March 22, 2026; Accepted: April 07, 2026; Published: April 29, 2026

African Journal of Infectious Diseases Research | Vol. 12, No. 4, April 2025 | pp. 157-168

DOI: 10.46882/AJIDR/148714

Article Type: Research Article

Title: Methicillin-resistant Staphylococcus aureus nasal carriage and surgical site infection rates following orthopedic implant procedures

Names of Authors: Connor MacLeod¹, Ananya Rao², Lucas Oliveira³*

Authors’ Affiliations: ¹Department of Orthopedic Surgery, University of Edinburgh, Edinburgh, United Kingdom. ²Department of Clinical Microbiology, Manipal Academy of Higher Education, Manipal, India. ³Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

Abstract: Nasal colonization with methicillin-resistant Staphylococcus aureus is a recognized endogenous reservoir for postoperative surgical site infections in orthopedic surgery. This study evaluated preoperative nasal carriage rates and their association with deep implant-related infections. Nasal swabs were collected from 480 patients prior to elective arthroplasty and screened via chromogenic agar and mecA gene PCR. Preoperative MRSA colonization was detected in 11.5 percent of patients, and postoperative surgical site infections developed in 14.5 percent of carriers compared to 2.1 percent of non-carriers. Molecular typing confirmed genetic concordance between preoperative nasal isolates and subsequent wound pathogens in 87.5 percent of infected carriers. Preoperative screening combined with targeted mupirocin decolonization and vancomycin prophylaxis significantly reduces prosthetic joint infection risks.

Keywords: Methicillin-resistant Staphylococcus aureus, Nasal carriage, Surgical site infection, Orthopedic implants, Decolonization

Citation: MacLeod C, Rao A, Oliveira L (2026). Methicillin-resistant Staphylococcus aureus nasal carriage and surgical site infection rates following orthopedic implant procedures. African Journal of Infectious Diseases Research, 12(4): 157–168. DOI: 10.46882/AJIDR/148714

Manuscript Timeline: Received: February 19, 2026; Revised: March 22, 2026; Accepted: April 07, 2026; Published: April 29, 2026

African Journal of Infectious Diseases Research | Vol. 12, No. 4, April 2025 | pp. 145-156

DOI: 10.46882/AJIDR/148713

Article Type: Research Article

Title: Seroprevalence and neurologic manifestations of West Nile virus infection among patients presenting with acute viral encephalitis

Names of Authors: Aleksandar Petrovic¹, Naledi Khumalo², Ji-Hoon Park³*

Authors’ Affiliations: ¹Clinic for Infectious and Tropical Diseases, University of Belgrade, Belgrade, Serbia. ²Department of Neurology, University of the Witwatersrand, Johannesburg, South Africa. ³Department of Microbiology, Seoul National University, Seoul, South Korea.

Abstract: West Nile virus is an emerging neurotropic flavivirus capable of causing severe meningitis, encephalitis, and acute flaccid paralysis. We investigated the frequency of acute West Nile virus infection and characterized clinical outcomes among patients hospitalized with suspected viral encephalitis. Cerebrospinal fluid and serum samples from 215 patients were tested using IgM antibody-capture ELISA and real-time reverse transcription PCR. Acute West Nile virus neuroinvasive disease was confirmed in 17.2 percent of cases, predominantly affecting adults over sixty years of age. Altered mental status, tremors, and cerebrospinal fluid pleocytosis were prominent clinical features, with an overall in-hospital mortality rate of 13.5 percent. Strengthening mosquito surveillance and clinical diagnostic awareness during late summer and early autumn is vital for timely supportive management.

Keywords: West Nile virus, Viral encephalitis, Neuroinvasive disease, Flavivirus, Cerebrospinal fluid

Citation: Petrovic A, Khumalo N, Park JH (2026). Seroprevalence and neurologic manifestations of West Nile virus infection among patients presenting with acute viral encephalitis. African Journal of Infectious Diseases Research, 12(4): 145–156. DOI: 10.46882/AJIDR/148713

Manuscript Timeline: Received: February 18, 2026; Revised: March 21, 2026; Accepted: April 06, 2026; Published: April 29, 2026